ReviewAdvances in therapy2020

The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current Evidence.

Brian G Feagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.